ScopusElsevier Scopus
Status
Active
Coverage
2009–present
Source type
Journal
Open access
No
CiteScore
126.6
SJR · SCImago
28.076
Q1 SJR quartile
H-index
259
Best quartile
Q1 · 99th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 2 / 428 | 99th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology is Scopus-indexed (Q1, CiteScore 126.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Nature Publishing Group.
Checked against the index lists dated .
ISSN 1759-4774Verify ISSN ↗1759-4782Verify ISSN ↗
Publisher: Nature Publishing Group
Scopus · Q1WoS · SCIEONOS
126.6
CiteScore 2025
Q1
Best quartile
2
Indexed in
Cost to publish: No APC data — check the publisher
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Nature Reviews Clinical Oncology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q1, CiteScore 126.6.
What quartile is Nature Reviews Clinical Oncology in Scopus?
Nature Reviews Clinical Oncology is Q1 in Oncology (rank 2 of 428), by CiteScore 2025.
What is the impact factor of Nature Reviews Clinical Oncology?
Nature Reviews Clinical Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 126.6, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 28.076, quartile Q1, with an H-index of 259.
Who publishes Nature Reviews Clinical Oncology and what is its ISSN?
Nature Reviews Clinical Oncology is published by Nature Publishing Group. Its print ISSN is 1759-4774 and its online ISSN is 1759-4782.
Is Nature Reviews Clinical Oncology covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Nature Reviews Clinical Oncology in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Nature Reviews Clinical Oncology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Nature Reviews Clinical Oncology? — open metrics via OpenAlex
Nature Reviews Clinical Oncology has an h-index of 288 and a 2-year mean of 28.29 citations per paper (OpenAlex). Its Scopus CiteScore is 126.6, quartile Q1. On 2-year citations it ranks #5 of 424 Scopus journals in Oncology.
288
h-index
28.29
2-yr mean citations
1,217
i10-index
3,372
works indexed
309,272
total citations
2-yr mean citations, among Scopus journals in the same subject
#5 of 424 Top 2% Oncology
Nature Reviews Clinical Oncology published 131 papers in 2025; its busiest recent year was 2017 with 210. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Nature Reviews Clinical Oncology? — latest 71 articles, 2025–2026
In its latest 71 research articles (2025–2026), authors are most often from United States (45.8%), Canada (6.3%) and Italy (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Nature Reviews Clinical Oncology? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 0.6 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Nature Reviews Disease Primers Scopus Q1 WoS SCIE Nature Reviews Endocrinology Scopus Q1 WoS SCIE Nature Reviews Materials Scopus Q1 WoS SCIE Nature Reviews Psychology Scopus Q1 WoS SSCI Nature Structural Biology Not in these indexes Nature Sustainability Scopus Q1 WoS SCIE/SSCI Nature Synthesis Scopus Q1 WoS ESCI NPG Asia Materials Scopus Q1 WoS SCIE DOAJ
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.